Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,585Revenue $M94.8Net Margin (%)-19.8Altman Z-Score18.9
Enterprise Value $M3,273EPS $-0.1Operating Margin %-8.8Piotroski F-Score4
P/E(ttm)--Beneish M-Score-1.6Pre-tax Margin (%)-19.8Higher ROA y-yY
Price/Book10.710-y EBITDA Growth Rate %--Quick Ratio18.6Cash flow > EarningsY
Price/Sales35.75-y EBITDA Growth Rate %--Current Ratio18.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-7.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-12.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M146ROIC % (ttm)-538.3Gross Margin Increase y-yN

Gurus Latest Trades with DYAX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DYAXKen Fisher 2015-03-31 Buy 0.01%$13.55 - $17.54
($15.57)
$ 24.6158%New holding182,450
DYAXJoel Greenblatt 2015-03-31 Sold Out -0.006%$13.55 - $17.54
($15.57)
$ 24.6158%Sold Out0
DYAXJoel Greenblatt 2014-06-30 Buy 0.01%$6.11 - $9.96
($7.59)
$ 24.61224%New holding46,505
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DYAX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


DYAX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BLAIR HENRY EDirector 2015-07-20Sell50,000$27.05-9.02view
MCLACHLAN DAVID JDirector 2015-06-08Sell75,000$25.63-3.98view
Ashe Andrew D.General Counsel & EVP 2015-03-06Sell2,400$15.558.77view
Christensen GustavCEO and President 2015-03-05Sell6,250$15.8655.17view
ADELMAN BURT ACMO & EVP, R&D 2015-03-05Sell9,375$15.6657.15view
MIGAUSKY GEORGE VEVP & CFO 2015-03-05Sell5,000$15.8655.17view
Ashe Andrew D.General Counsel & EVP 2015-02-26Sell1,500$15.3460.43view
MIGAUSKY GEORGE VEVP & CFO 2015-02-24Sell9,000$15.6457.35view
Christensen GustavCEO and President 2015-02-24Sell18,750$15.6457.35view
ADELMAN BURT ACMO & EVP, R&D 2015-01-02Sell75,000$14.0575.16view

Quarterly/Annual Reports about DYAX:

News about DYAX:

Articles On GuruFocus.com
Voltari Corp. (VLTC) Under Carl Icahn Umbrella, Dyax Corp. (DYAX) Potential Angioedema Preventive Tr Apr 01 2015 
Weekly CFO Buys Highlight: DYAX, IBI, FARM, TAP, DBM Mar 19 2011 
Dyax Corp. (DYAX) CEO Gustav Christensen buys 10,000 Shares Mar 15 2011 
Dyax Corp. (DYAX) CEO Gustav Christensen buys 10,000 Shares Mar 15 2011 
Dyax Corp. Reports Operating Results (10-K) Mar 02 2011 
Dyax Corp. Reports Operating Results (10-Q) Nov 02 2010 
Dyax Corp. (DYAX) CEO Gustav Christensen buys 5,000 Shares Sep 15 2010 
Dyax Corp. (DYAX) CFO George V Migausky buys 12,000 Shares Aug 25 2010 
Weekly CFO Buys Highlight: Apollo Investment Corp., Dyax Corp., Heska Corp., Vaughan Foods Inc., Wir Jun 05 2010 
Weekly CFO Buy Highlights: F.N.B. Corp, Great Wolf Resorts Inc, Dyax Corp, Transcat Inc, Cal Dive In Jun 20 2009 

More From Other Websites
10-Q for Dyax Corp. Aug 01 2015
DYAX CORP Files SEC form 10-Q, Quarterly Report Jul 30 2015
Edited Transcript of DYAX earnings conference call or presentation 29-Jul-15 9:00pm GMT Jul 29 2015
Dyax reports 2Q loss Jul 29 2015
Dyax reports 2Q loss Jul 29 2015
DYAX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Jul 29 2015
Dyax Corp. Announces Second Quarter 2015 Financial Results Jul 29 2015
Dyax Corp. Announces Second Quarter 2015 Financial Results Jul 29 2015
Q2 2015 Dyax Corp Earnings Release - Time Not Supplied Jul 29 2015
Dyax Corp. to Host Second Quarter 2015 Earnings Call and Webcast Jul 15 2015
Dyax Corp. to Host Second Quarter 2015 Earnings Call and Webcast Jul 15 2015
Dyax Hereditary Angioedema Drug Gets Breakthrough Status - Analyst Blog Jul 08 2015
RA Capital’s Latest Move In Alcobra Ltd (ADHD) Coming Off Hefty Second Quarter Gains Jul 08 2015
What FDA Breakthrough Therapy Designation Means for Dyax Jul 07 2015
Dyax banks on drug designation news Jul 07 2015
Dyax Corp. Receives FDA Breakthrough Therapy Designation for DX-2930 for Prevention of Attacks of... Jul 07 2015
Dyax Corp. Receives FDA Breakthrough Therapy Designation for DX-2930 for Prevention of Attacks of... Jul 07 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK